Stock of this pharmaceutical company surged heavily by 9.60 per cent today!
Stock of this pharmaceutical company surged heavily by 9.60 per cent today!

Stock of this pharmaceutical company surged heavily by 9.60 per cent today!

Company’s shares jumped after receiving approval from Brazil’s National Health Surveillance Agency for its injectable formulations manufacturing units.

DSIJ Intelligence Article rating: 4.6

Company’s shares jumped after receiving approval from Brazil’s National Health Surveillance Agency for its injectable formulations manufacturing units.

DSIJ MINDSHARE

Mkt Commentary3-Apr, 2025

Mindshare3-Apr, 2025

Multibaggers3-Apr, 2025

Multibaggers3-Apr, 2025

Multibaggers2-Apr, 2025

Knowledge

General22-Mar, 2025

MF14-Mar, 2025

MF14-Mar, 2025

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR